Sulphate Accumulation in Prostate
NCT02821728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2017-06-02
Summary
This study evaluates whether a broccoli intervention (≥ 4 weeks) will result in differences in tissue sulphate levels in men scheduled for prostate biopsies. Comparisons will be made between participants randomised to the broccoli-rich diet and those randomised to the non-intervention arm.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Dietary intervention
Participants in this group will consume three portions of broccoli and stilton soup per week for a minimum of four weeks before their scheduled template prostate biopsy. The soup will be made with a specially cultivated broccoli known as Beneforte, which contains an enhanced dose of a substance called glucoraphanin.
- OTHER
-
Normal diet
Participants in this group will continue with their normal diet up until the day of their scheduled template prostate biopsy.
Sponsors & Collaborators
-
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
collaborator OTHER -
Quadram Institute Bioscience
lead OTHER
Principal Investigators
-
Richard Mithen, PhD · Quadram Institute Bioscience
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2016-12-31
- Completion
- 2017-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation
NCT00154843 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Effect of Fucoidan on Prostate Health in Males With Benign Prostatic Hyperplasia
NCT06487871 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
NCT00201630 ·Status: UNKNOWN ·Phase: PHASE3
-
CBD-based Therapy to Attenuate Non-bacterial Prostatitis Symptoms
NCT06968910 ·Status: COMPLETED ·Phase: NA
-
Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
NCT01441713 ·Status: COMPLETED
-
Herbal Supplement Prosta-OK® Neo as an Adjunct Therapy in Patients With Mild to Severe Non-neurogenic Male Lower Urinary Tract Symptoms Receiving Tamsulosin Therapy
NCT04418635 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers
NCT02873117 ·Status: COMPLETED
-
Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto
NCT00797394 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia
NCT00861588 ·Status: COMPLETED ·Phase: NA
-
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer
NCT00544076 ·Status: TERMINATED ·Phase: PHASE3
-
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
NCT04029714 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
High Risk Prostate Cancer Prevention Study
NCT01174953 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPH
NCT04590534 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
NCT01021267 ·Status: UNKNOWN ·Phase: PHASE4
-
ALA and Prostate Cancer
NCT00309439 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
NCT00866554 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effects of a Prostate Health Formulation
NCT02886832 ·Status: COMPLETED ·Phase: NA
-
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
NCT03297398 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Dr. Pyke's Supplement for Stream (S4S) in Men With Prostatism and ED
NCT03681392 ·Status: WITHDRAWN ·Phase: NA
-
A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice
NCT06748456 ·Status: RECRUITING ·Phase: NA
-
The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
NCT01484808 ·Status: UNKNOWN
-
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
NCT01254071 ·Status: COMPLETED ·Phase: PHASE1
-
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors
NCT01105130 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression
NCT01716104 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Chronic Bacterial Prostatitis
NCT02130713 ·Status: COMPLETED ·Phase: PHASE4